Literature DB >> 7193318

Infant of the diabetic mother: review of 225 cases.

J A Lemons, P Vargas, J J Delaney.   

Abstract

The maternal and neonatal data on 225 infants of diabetic mothers (IDM) are presented. The incidence of maternal and neonatal complications confirms previous reports, indicating improved survival rates and decreasing neonatal morbidity for the IDM. The observed incidence of hyaline membrane disease was 2.8%, perhaps reflecting attempts to prolong pregnancy when possible to 39 weeks' gestation with judicious use of primary cesarean section. Further, from analysis of neonatal growth, the head circumference of the large-for-gestational-age infant was found to be significantly increased after 37 weeks' gestation. Whether or not this observation represents increased brain growth in these infants is not known.

Entities:  

Mesh:

Year:  1981        PMID: 7193318

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  A case-control study of major congenital heart defects in Sweden--1981-1986.

Authors:  P Pradat
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

2.  Are all infants of diabetic mothers "macrosomic"?

Authors:  R J Bradley; K H Nicolaides; J M Brudenell
Journal:  BMJ       Date:  1988-12-17

Review 3.  Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis.

Authors:  Rinat Gabbay-Benziv; E Albert Reece; Fang Wang; Peixin Yang
Journal:  World J Diabetes       Date:  2015-04-15

4.  Maternal blood glucose control and outcome of diabetic pregnancy.

Authors:  A D Wright; K G Taylor; H O Nicholson; J Insley; S E Evans
Journal:  Postgrad Med J       Date:  1982-07       Impact factor: 2.401

5.  Beta glucuronidase and hyperbilirubinaemia in breast fed infants of diabetic mothers.

Authors:  L Sirota; M Ferrera; N Lerer; F Dulitzky
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

6.  Pregnancy in diabetic women: outcome with a program aimed at normoglycemia before meals.

Authors:  G J Tevaarwerk; P G Harding; K J Milne; N T Jaco; N W Rodger; C Hurst
Journal:  Can Med Assoc J       Date:  1981-09-01       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.